Project description
E-health platform for gastrointestinal diagnostics and therapy
The EU-funded eCAP project aims to create an innovative medical device as a combination of a smart capsule with an e-health platform for diagnostics, disease management and improved outcomes for patients with gastrointestinal (GI) diseases. The project will create a modular implantable capsule with a multi-sensing capacity for GI physiology monitoring. It will utilise smartphone communication with cloud computing technology and application interfaces to integrate, process and interpret longitudinal physiological data collected by the capsule. The personalised tests will provide accurate results from the multi-stream data input with AI-aided interpretation. The ambitious goal is to facilitate a shift in GI diagnostics to a patient-centred e-health approach and connected medical devices for remote patient monitoring.
Objective
eCAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics, patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases. Our project will create a modular and implantable capsule with multi-sensing capacity that enables GI physiology monitoring for a controlled time period, leveraging the minimally invasive surgical approach of flexible endoscopy. eCAP will use a worldwide ubiquitous smartphone communication standard, together with cloud computing technology and application interfaces to integrate, process and interpret longitudinal physiological data collected by the capsule. The digital platform is designed to improve the accuracy and clinical usefulness of standard test data by incorporating patient reported outcome measures. The clinician is able to personalize the test for the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by Artificial Intelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctors worldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings using gastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluation with health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developed to train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantable capsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue version to a patient centered e-health tool and to make Europe the leader in the rapidly growing field of connected medical devices for remote patient monitoring.
Fields of science
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health sciencesbasic medicinephysiology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- medical and health sciencesclinical medicinegastroenterology
Keywords
Programme(s)
Funding Scheme
HORIZON-IA - HORIZON Innovation ActionsCoordinator
67000 Strasbourg
France